RFA-DA-23-049 - HEAL Initiative: Therapeutics Development for Opioid Use Disorder in Patients with Co-occurring Mental Disorders (UG3/UH3 - Clinical Trial Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)
Active NOSIs
| Title | Notice Number | Organization | Release Date | Expiration Date | Activity Code(s) |
|---|---|---|---|---|---|
| Notice of Participation of the National Institute on Aging (NIA) in RFA-DA-23-049, "HEAL Initiative: Therapeutics Development for Opioid Use Disorder in Patients with Co-occurring Mental Disorders (UG3/UH3 - Clinical Trial Optional)" | NOT-AG-22-036 | NIA | Sep 9, 2022 | Oct 10, 2026 | UG3/UH3 |
For technical issues E-mail OER Webmaster